Search Results
May 07, 2026, 16:05 ET 10x Genomics Reports First Quarter 2026 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2026.
More news about: 10x Genomics, Inc.
Apr 29, 2026, 16:05 ET 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities
More news about: 10x Genomics, Inc.
Apr 29, 2026, 09:00 ET The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
(NASDAQ: SENS), TransMedics Group (NASDAQ: TMDX), WELL Health Technologies (TSX: WELL) (OTCQX: WHTCF), and 10x Genomics (NASDAQ: TXG).
More news about: Equity Insider
Apr 18, 2026, 22:00 ET 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome
More news about: 10x Genomics, Inc.
Apr 15, 2026, 16:05 ET 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended March 31, 2026 after market close
More news about: 10x Genomics, Inc.
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
10x Genomics, Inc. (Nasdaq: TXG) and
More news about: Bioptimus
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
10x Genomics, Inc. (Nasdaq: TXG) and
More news about: Bioptimus
Mar 17, 2026, 08:00 ET PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
Zheng, Ph.D., co-founder and CEO of PerturbAI.PerturbAI collaborated with NVIDIA, the Allen Institute for Brain Science, and 10x Genomics (Nasdaq: TXG) to generate and analyze the atlas, which enables systematic evaluation of the brain genome, providing a framework to distinguish causal mechanisms from
More news about: PerturbAI
Feb 19, 2026, 16:05 ET 10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen
More news about: 10x Genomics, Inc.
Feb 12, 2026, 16:05 ET 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided
More news about: 10x Genomics, Inc.
Feb 04, 2026, 09:00 ET PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that
More news about: 10x Genomics, Inc.
Jan 22, 2026, 16:05 ET 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2025
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:11 ET 10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center,
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:10 ET 10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to analyze tumor samples from patients
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:00 ET Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with the Cancer Research Institute (CRI) to advance the frontiers of immuno-oncology
More news about: 10x Genomics, Inc.
Jan 11, 2026, 12:00 ET 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December
More news about: 10x Genomics, Inc.
Dec 29, 2025, 16:05 ET 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan
More news about: 10x Genomics, Inc.
Nov 18, 2025, 09:00 ET New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, the Garvan Institute of Medical Research in Australia and the University of Tokyo in Japan, today announced
More news about: 10x Genomics, Inc.
Nov 11, 2025, 16:05 ET 10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research
More news about: 10x Genomics, Inc.
Nov 06, 2025, 16:05 ET 10x Genomics Reports Third Quarter 2025 Financial Results
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025.
More news about: 10x Genomics, Inc.
Oct 29, 2025, 09:45 ET Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
positioned in historically productive gold districts: GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF), Torex Gold Resources Inc. (TSX: TXG) (OTCQX: TORXF), GoldQuest Mining Corp. (TSXV: GQC), White Gold Corp. (TSXV: WGO) (OTCQX: WHGOF), and Hycroft Mining Holding Corporation
More news about: USA News Group
Oct 29, 2025, 09:00 ET 10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible
More news about: 10x Genomics, Inc.
Oct 20, 2025, 12:30 ET 10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and Anthropic, an AI safety and research company and creator of Claude, today announced a collaboration
More news about: 10x Genomics, Inc.
Oct 09, 2025, 16:05 ET 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market
More news about: 10x Genomics, Inc.
Sep 09, 2025, 09:00 ET CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
Yeda, the commercial arm of the Weizmann Institute of Science, today announced a translational research collaboration with 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology and the Weizmann Institute. Together, the organizations are launching a multi-year, international clinical
More news about: 10x Genomics, Inc.